Knockdown of IGFBP5 in parental SLMT-1 cells confirmed that IGFBP5 suppression is one of the mechanisms for ESCC cells to acquire cisplatin-resistance. Here, IGFBP5 is linked to esophageal squamous cell carcinoma.